Misplaced Pages

#806193

21-455: WHMIS is an example of synchronization and cooperation amongst Canada's federal, provincial and territorial governments. The coordinated approach avoided duplication, inefficiency through loss of scale and the interprovincial trade barriers that would have been created had each province and territory established its own hazard communication system. The federal Hazardous Products Act and associated Controlled Products Regulations , administered by

42-518: A report on CBC Television questioned the safety of drugs sold in North America . The Canadian Press reported that Health Canada is secretive regarding inspections about drugs manufactured overseas, leaving the public unsure about the safety of these drugs. Health Canada aims to provide responses to pharmaceutical innovators within 300 days of submitting a drug for review. However, for submissions filed between 2015 and 2019, only 33 percent received

63-501: A response within that target. Fully 18 percent waited over a year, and almost 5 percent over two years. The average delay for a standard review was 335 days. Health Canada's accelerated pathway for approval dubbed "conditional compliance" reduces its target timeline to 200 days, but its actual average delay was still 302 days, and only 8 percent of applicants received responses within the 200-day target. It has been suggested that government entities should make use of rolling submissions, as

84-442: A series of legislations at both the federal and provisional and territory levels. WHMIS 1988 was phased out from 2015 to 2018, with the old system being completely phased out on 1 December, 2018. All substances that WHMIS applied, 'controlled products', fell into one of the six general WHMIS classes: The 1988 system included eight symbols, one per classification, except for Class D , which had three symbols, one for each division of

105-432: A variety of healthcare , agricultural , and pharmaceutical activities. This responsibility also involves extensive collaboration with various other federal- and provincial-level organizations in order to ensure the safety of food, health, and pharmaceutical products—including the regulation of health research and pharmaceutical manufacturing / testing facilities. The department is responsible to Parliament through

126-591: Is a shared responsibility between Health Canada and the Public Health Agency of Canada . Acts for which Health Canada has total or partial responsibility: Acts which Health Canada is involved or has special interest in: Health Canada has a special access program that health care providers may use to request medications that are not currently commercially available in Canada. The chief medical advisor of Health Canada, Supriya Sharma, as of April 2021, oversees

147-564: Is divided into six distinct programs: Health Canada's Canada Vigilance Program (CVP) "collects and assesses reports of suspected adverse reactions to health products marketed in Canada," including prescription and over-the-counter medications , natural health products , biotechnology products , vaccines , blood products , human cell products , human tissue products, human organs , disinfectants and radiopharmaceuticals . The program has been in effect since 1965. Pharmacovigilance related to Adverse Events Following Immunization (AEFI)

168-924: The COVID-19 vaccine approval process in Canada. On 29 March 2021, Sharma supported the National Advisory Committee on Immunization 's declaration of a pause for the administration of the AstraZeneca vaccine to Canadians under the age of 55. An editorial published by the Canadian Medical Association Journal has called for Health Canada to more strictly regulate natural health products . The editorial cited weaknesses in current legislation that allow natural health products to make baseless health claims, to neglect side-effects research prior to products reaching market, and to be sold without being evaluated by Health Canada. On 10 September 2012,

189-588: The Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for workplace chemicals." A notable difference in the WHMIS adoption of GHS was the inclusion of a 'biohazard' hazard pictogram, retained from the original WHMIS 1988 pictograms. The standard GHS pictograms do not include a specific symbol for biohazards. WHMIS 2015 was phased into use over a three year period from February 2015 to December 2018. By 1 December 2018, use of WHMIS 2015

210-414: The minister of health —presently Mark Holland —as part of the federal health portfolio. The minister is aided by the associate minister of health , and minister of mental health and addictions —presently Ya'ara Saks . The deputy minister of health, the senior most civil servant within the department, is responsible for the day-to-day leadership and operations of the department and reports directly to

231-865: The American-based company Emergent Biosolutions , a global specialty biopharmaceutical company. The PHAC has identified botulism as a likely biological terrorist threat. The Compliance and Enforcement Directorate provides support to Health Canada by enforcing the laws and regulations pertaining to the production, distribution, importation, sale, and/or use of consumer products, including but not limited to: tobacco , pest control materials , drugs and medical devices , biologics , and natural health products. The Directorate conducts inspections and investigations to ensure that products are safe, of good quality, and properly labelled and distributed, in order to better protect Canadians from potentially harmful products and consumables. Compliance and Enforcement Directorate

SECTION 10

#1732869105807

252-605: The Workplace Hazardous Materials Bureau residing in the federal Department of Health Canada , established the national standard for chemical classification and hazard communication in Canada and is the foundation for the workers' "right-to-know" legislation enacted in each of Canada's provinces and territories. Under the Constitution of Canada , labour legislation falls primarily under the jurisdiction of Canada's provinces and territories. The Labour Program, of

273-581: The class. Health Canada Health Canada ( HC ; French : Santé Canada, SC ) is the department of the Government of Canada responsible for national health policy . The department itself is also responsible for numerous federal health-related agencies, including the Canadian Food Inspection Agency (CFIA) and the Public Health Agency of Canada (PHAC), among others. These organizations help to ensure compliance with federal law in

294-530: The federal government Department of Human Resources and Skills Development Canada , is the occupational health and safety (OHS) regulatory authority for the approximately 10% of workplaces designated to be under federal jurisdiction. As such, each of the thirteen federal, provincial and territorial (FPT) agencies responsible for OHS has established employer WHMIS requirements within their respective jurisdiction. These requirements place an onus on employers to ensure that controlled products used, stored or handled in

315-648: The jurisdiction of Health Canada: In their responsibility of maintaining and improving the health of Canadians, the Minister of Health is supported by the Health Portfolio, which comprises Health Canada as well as: Additionally, Health Canada is a corporate partner of the Canadian Association of Emergency Physicians (CAEP). In December 2016, Health Canada approved the purchase of a new botulism antitoxin called heptavalent botulism antitoxin (BAT) from

336-534: The minister. Originally created as the "Department of Health" in 1919—in the wake of the Spanish flu crisis —what is known as Health Canada today was formed in 1993 from the former Health and Welfare Canada department (established in 1944), which split into two separate units; the other department being Human Resources and Labour Canada . Health Canada's leadership consists of: The following branches, offices, and bureaus (and their respective services) fall under

357-517: The safe usage of hazardous materials and report issues such as damaged or missing container labels. Even after the move from WHMIS 1988 to WHMIS 2015, this structure of shared responsibility is retained, largely unchanged. On February 11, 2015, the Government of Canada published in the Canada Gazette a new modified version of the WHMIS system called WHMIS 2015 . WHMIS 2015 was created "to incorporate

378-606: The system. The system divides responsibility among the various levels of a product, with suppliers, employers and workers each having a role in WHMIS. Suppliers are distributing 'hazardous products', must ensure containers are properly marked, SDS documentation is accurate and provided to customers. Employers are responsible for the training of their workers on the safe usage of hazardous products and any risks they pose, providing safe storage and labeled containers, and ensure availability of SDS to workers. Workers are expected to take part in WHMIS trainings, follow training and instructions on

399-401: The workplace are properly labelled, that material safety data sheets are made available to workers, and that workers receive education and site-specific training to ensure the safe storage, handling and use of controlled products in the workplace. The development of WHMIS 1988 was a collaborative effort, involving Industry, organized labour and governments as part of a advisory body to develop

420-452: Was done for COVID-19 vaccines, to proceed with the examination of partially complete submissions and accept new information as it becomes available, and also that drugs already approved in other jurisdictions should be approved more rapidly to avoid redundancy. Structure of the Canadian federal government#Departments, with subsidiary units Too Many Requests If you report this error to

441-477: Was mandatory by manufacturers/importers, distributors and employers. WHMIS 2015 regulations cover materials, referred to as a 'hazardous products' used in a workplace, that meets the criteria of hazard classification, such as toxicity , flash point . These are classified as 'hazardous product': The following were exempt from WHMIS, and are in most cases subject to legislation specific to the material: The original WHMIS went into effect 31 October 1988, as part of

SECTION 20

#1732869105807
#806193